Global Vaccin Antirabic Market Growth 2020-2025
According to this study, over the next five years the Vaccin Antirabic market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Vaccin Antirabic business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccin Antirabic market by type, application, key manufacturers and key regions and countries.
This study considers the Vaccin Antirabic value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Gopher Kidney Cell Vaccine
Freeze-Dried Vero Cell Vaccine
Common Vero Cell Vaccines
Human Diploid Vaccine
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Pre-exposure Prophylaxis
After Exposure Prophylaxis
Additional Doses
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GSK
Zhongke Biological
Sanofi
Yisheng
Merck
Chengda
BCHT
VACN
Hissen
Changsheng
Ningbo Rongan Biological Pharmaceutical
Guangzhou Nuocheng Biological
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Vaccin Antirabic consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Vaccin Antirabic market by identifying its various subsegments.
Focuses on the key global Vaccin Antirabic manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vaccin Antirabic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Vaccin Antirabic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccin Antirabic Consumption 2015-2025
2.1.2 Vaccin Antirabic Consumption CAGR by Region
2.2 Vaccin Antirabic Segment by Type
2.2.1 Gopher Kidney Cell Vaccine
2.2.2 Freeze-Dried Vero Cell Vaccine
2.2.3 Common Vero Cell Vaccines
2.2.4 Human Diploid Vaccine
2.3 Vaccin Antirabic Consumption by Type
2.3.1 Global Vaccin Antirabic Consumption Market Share by Type (2015-2020)
2.3.2 Global Vaccin Antirabic Revenue and Market Share by Type (2015-2020)
2.3.3 Global Vaccin Antirabic Sale Price by Type (2015-2020)
2.4 Vaccin Antirabic Segment by Application
2.4.1 Pre-exposure Prophylaxis
2.4.2 After Exposure Prophylaxis
2.4.3 Additional Doses
2.5 Vaccin Antirabic Consumption by Application
2.5.1 Global Vaccin Antirabic Consumption Market Share by Type (2015-2020)
2.5.2 Global Vaccin Antirabic Value and Market Share by Type (2015-2020)
2.5.3 Global Vaccin Antirabic Sale Price by Type (2015-2020)
3 Global Vaccin Antirabic by Company
3.1 Global Vaccin Antirabic Sales Market Share by Company
3.1.1 Global Vaccin Antirabic Sales by Company (2018-2020)
3.1.2 Global Vaccin Antirabic Sales Market Share by Company (2018-2020)
3.2 Global Vaccin Antirabic Revenue Market Share by Company
3.2.1 Global Vaccin Antirabic Revenue by Company (2018-2020)
3.2.2 Global Vaccin Antirabic Revenue Market Share by Company (2018-2020)
3.3 Global Vaccin Antirabic Sale Price by Company
3.4 Global Vaccin Antirabic Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Vaccin Antirabic Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Vaccin Antirabic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Vaccin Antirabic by Regions
4.1 Vaccin Antirabic by Regions
4.2 Americas Vaccin Antirabic Consumption Growth
4.3 APAC Vaccin Antirabic Consumption Growth
4.4 Europe Vaccin Antirabic Consumption Growth
4.5 Middle East & Africa Vaccin Antirabic Consumption Growth
5 Americas
5.1 Americas Vaccin Antirabic Consumption by Countries
5.1.1 Americas Vaccin Antirabic Consumption by Countries (2015-2020)
5.1.2 Americas Vaccin Antirabic Value by Countries (2015-2020)
5.2 Americas Vaccin Antirabic Consumption by Type
5.3 Americas Vaccin Antirabic Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Vaccin Antirabic Consumption by Regions
6.1.1 APAC Vaccin Antirabic Consumption by Regions (2015-2020)
6.1.2 APAC Vaccin Antirabic Value by Regions (2015-2020)
6.2 APAC Vaccin Antirabic Consumption by Type
6.3 APAC Vaccin Antirabic Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Vaccin Antirabic by Countries
7.1.1 Europe Vaccin Antirabic Consumption by Countries (2015-2020)
7.1.2 Europe Vaccin Antirabic Value by Countries (2015-2020)
7.2 Europe Vaccin Antirabic Consumption by Type
7.3 Europe Vaccin Antirabic Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Vaccin Antirabic by Countries
8.1.1 Middle East & Africa Vaccin Antirabic Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Vaccin Antirabic Value by Countries (2015-2020)
8.2 Middle East & Africa Vaccin Antirabic Consumption by Type
8.3 Middle East & Africa Vaccin Antirabic Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vaccin Antirabic Distributors
10.3 Vaccin Antirabic Customer
11 Global Vaccin Antirabic Market Forecast
11.1 Global Vaccin Antirabic Consumption Forecast (2021-2025)
11.2 Global Vaccin Antirabic Forecast by Regions
11.2.1 Global Vaccin Antirabic Forecast by Regions (2021-2025)
11.2.2 Global Vaccin Antirabic Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Vaccin Antirabic Forecast by Type
11.8 Global Vaccin Antirabic Forecast by Application
12 Key Players Analysis
12.1 GSK
12.1.1 Company Information
12.1.2 Vaccin Antirabic Product Offered
12.1.3 GSK Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GSK Latest Developments
12.2 Zhongke Biological
12.2.1 Company Information
12.2.2 Vaccin Antirabic Product Offered
12.2.3 Zhongke Biological Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Zhongke Biological Latest Developments
12.3 Sanofi
12.3.1 Company Information
12.3.2 Vaccin Antirabic Product Offered
12.3.3 Sanofi Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sanofi Latest Developments
12.4 Yisheng
12.4.1 Company Information
12.4.2 Vaccin Antirabic Product Offered
12.4.3 Yisheng Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Yisheng Latest Developments
12.5 Merck
12.5.1 Company Information
12.5.2 Vaccin Antirabic Product Offered
12.5.3 Merck Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Merck Latest Developments
12.6 Chengda
12.6.1 Company Information
12.6.2 Vaccin Antirabic Product Offered
12.6.3 Chengda Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Chengda Latest Developments
12.7 BCHT
12.7.1 Company Information
12.7.2 Vaccin Antirabic Product Offered
12.7.3 BCHT Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 BCHT Latest Developments
12.8 VACN
12.8.1 Company Information
12.8.2 Vaccin Antirabic Product Offered
12.8.3 VACN Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 VACN Latest Developments
12.9 Hissen
12.9.1 Company Information
12.9.2 Vaccin Antirabic Product Offered
12.9.3 Hissen Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Hissen Latest Developments
12.10 Changsheng
12.10.1 Company Information
12.10.2 Vaccin Antirabic Product Offered
12.10.3 Changsheng Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Changsheng Latest Developments
12.11 Ningbo Rongan Biological Pharmaceutical
12.11.1 Company Information
12.11.2 Vaccin Antirabic Product Offered
12.11.3 Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Ningbo Rongan Biological Pharmaceutical Latest Developments
12.12 Guangzhou Nuocheng Biological
12.12.1 Company Information
12.12.2 Vaccin Antirabic Product Offered
12.12.3 Guangzhou Nuocheng Biological Vaccin Antirabic Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Guangzhou Nuocheng Biological Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Vaccin Antirabic Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Gopher Kidney Cell Vaccine
Table 5. Major Players of Freeze-Dried Vero Cell Vaccine
Table 6. Major Players of Common Vero Cell Vaccines
Table 7. Major Players of Human Diploid Vaccine
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Vaccin Antirabic Consumption Market Share by Type (2015-2020)
Table 10. Global Vaccin Antirabic Revenue by Type (2015-2020) ($ million)
Table 11. Global Vaccin Antirabic Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Vaccin Antirabic Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Vaccin Antirabic Consumption Market Share by Application (2015-2020)
Table 15. Global Vaccin Antirabic Value by Application (2015-2020)
Table 16. Global Vaccin Antirabic Value Market Share by Application (2015-2020)
Table 17. Global Vaccin Antirabic Sale Price by Application (2015-2020)
Table 18. Global Vaccin Antirabic Sales by Company (2017-2019) (K Units)
Table 19. Global Vaccin Antirabic Sales Market Share by Company (2017-2019)
Table 20. Global Vaccin Antirabic Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Vaccin Antirabic Revenue Market Share by Company (2017-2019)
Table 22. Global Vaccin Antirabic Sale Price by Company (2017-2019)
Table 23. Global Vaccin Antirabic Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Vaccin Antirabic Products Offered
Table 25. Vaccin Antirabic Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Vaccin Antirabic Consumption by Regions 2015-2020 (K Units)
Table 27. Global Vaccin Antirabic Consumption Market Share by Regions 2015-2020
Table 28. Global Vaccin Antirabic Value by Regions 2015-2020 ($ Millions)
Table 29. Global Vaccin Antirabic Value Market Share by Regions 2015-2020
Table 30. Americas Vaccin Antirabic Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Vaccin Antirabic Consumption Market Share by Countries (2015-2020)
Table 32. Americas Vaccin Antirabic Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Vaccin Antirabic Value Market Share by Countries (2015-2020)
Table 34. Americas Vaccin Antirabic Consumption by Type (2015-2020) (K Units)
Table 35. Americas Vaccin Antirabic Consumption Market Share by Type (2015-2020)
Table 36. Americas Vaccin Antirabic Consumption by Application (2015-2020) (K Units)
Table 37. Americas Vaccin Antirabic Consumption Market Share by Application (2015-2020)
Table 38. APAC Vaccin Antirabic Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Vaccin Antirabic Consumption Market Share by Countries (2015-2020)
Table 40. APAC Vaccin Antirabic Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Vaccin Antirabic Value Market Share by Regions (2015-2020)
Table 42. APAC Vaccin Antirabic Consumption by Type (2015-2020) (K Units)
Table 43. APAC Vaccin Antirabic Consumption Market Share by Type (2015-2020)
Table 44. APAC Vaccin Antirabic Consumption by Application (2015-2020) (K Units)
Table 45. APAC Vaccin Antirabic Consumption Market Share by Application (2015-2020)
Table 46. Europe Vaccin Antirabic Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Vaccin Antirabic Consumption Market Share by Countries (2015-2020)
Table 48. Europe Vaccin Antirabic Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Vaccin Antirabic Value Market Share by Countries (2015-2020)
Table 50. Europe Vaccin Antirabic Consumption by Type (2015-2020) (K Units)
Table 51. Europe Vaccin Antirabic Consumption Market Share by Type (2015-2020)
Table 52. Europe Vaccin Antirabic Consumption by Application (2015-2020) (K Units)
Table 53. Europe Vaccin Antirabic Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Vaccin Antirabic Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Vaccin Antirabic Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Vaccin Antirabic Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Vaccin Antirabic Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Vaccin Antirabic Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Vaccin Antirabic Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Vaccin Antirabic Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Vaccin Antirabic Consumption Market Share by Application (2015-2020)
Table 62. Vaccin Antirabic Distributors List
Table 63. Vaccin Antirabic Customer List
Table 64. Global Vaccin Antirabic Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Vaccin Antirabic Consumption Market Forecast by Regions
Table 66. Global Vaccin Antirabic Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Vaccin Antirabic Value Market Share Forecast by Regions
Table 68. Global Vaccin Antirabic Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Vaccin Antirabic Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Vaccin Antirabic Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Vaccin Antirabic Value Market Share Forecast by Type (2021-2025)
Table 72. Global Vaccin Antirabic Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Vaccin Antirabic Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Vaccin Antirabic Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Vaccin Antirabic Value Market Share Forecast by Application (2021-2025)
Table 76. GSK Product Offered
Table 77. GSK Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. GSK Main Business
Table 79. GSK Latest Developments
Table 80. GSK Basic Information, Company Total Revenue (in $ million), Vaccin Antirabic Manufacturing Base, Sales Area and Its Competitors
Table 81. Zhongke Biological Product Offered
Table 82. Zhongke Biological Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Zhongke Biological Main Business
Table 84. Zhongke Biological Latest Developments
Table 85. Zhongke Biological Basic Information, Company Total Revenue (in $ million), Vaccin Antirabic Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Product Offered
Table 87. Sanofi Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Sanofi Basic Information, Company Total Revenue (in $ million), Vaccin Antirabic Manufacturing Base, Sales Area and Its Competitors
Table 91. Yisheng Product Offered
Table 92. Yisheng Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Yisheng Main Business
Table 94. Yisheng Latest Developments
Table 95. Yisheng Basic Information, Company Total Revenue (in $ million), Vaccin Antirabic Manufacturing Base, Sales Area and Its Competitors
Table 96. Merck Product Offered
Table 97. Merck Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Merck Main Business
Table 99. Merck Latest Developments
Table 100. Merck Basic Information, Company Total Revenue (in $ million), Vaccin Antirabic Manufacturing Base, Sales Area and Its Competitors
Table 101. Chengda Product Offered
Table 102. Chengda Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Chengda Main Business
Table 104. Chengda Latest Developments
Table 105. Chengda Basic Information, Company Total Revenue (in $ million), Vaccin Antirabic Manufacturing Base, Sales Area and Its Competitors
Table 106. BCHT Product Offered
Table 107. BCHT Basic Information, Company Total Revenue (in $ million), Vaccin Antirabic Manufacturing Base, Sales Area and Its Competitors
Table 108. BCHT Main Business
Table 109. BCHT Latest Developments
Table 110. BCHT Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. VACN Product Offered
Table 112. VACN Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. VACN Main Business
Table 114. VACN Latest Developments
Table 115. VACN Basic Information, Company Total Revenue (in $ million), Vaccin Antirabic Manufacturing Base, Sales Area and Its Competitors
Table 116. Hissen Product Offered
Table 117. Hissen Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Hissen Main Business
Table 119. Hissen Latest Developments
Table 120. Hissen Basic Information, Company Total Revenue (in $ million), Vaccin Antirabic Manufacturing Base, Sales Area and Its Competitors
Table 121. Changsheng Product Offered
Table 122. Changsheng Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Changsheng Main Business
Table 124. Changsheng Latest Developments
Table 125. Changsheng Basic Information, Company Total Revenue (in $ million), Vaccin Antirabic Manufacturing Base, Sales Area and Its Competitors
Table 126. Ningbo Rongan Biological Pharmaceutical Product Offered
Table 127. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Ningbo Rongan Biological Pharmaceutical Main Business
Table 129. Ningbo Rongan Biological Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Ningbo Rongan Biological Pharmaceutical Latest Developments
Table 131. Guangzhou Nuocheng Biological Product Offered
Table 132. Guangzhou Nuocheng Biological Vaccin Antirabic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Guangzhou Nuocheng Biological Main Business
Table 134. Guangzhou Nuocheng Biological Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Guangzhou Nuocheng Biological Latest Developments
List of Figures
Figure 1. Picture of Vaccin Antirabic
Figure 2. Vaccin Antirabic Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Vaccin Antirabic Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Vaccin Antirabic Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Gopher Kidney Cell Vaccine
Figure 7. Product Picture of Freeze-Dried Vero Cell Vaccine
Figure 8. Product Picture of Common Vero Cell Vaccines
Figure 9. Product Picture of Human Diploid Vaccine
Figure 10. Global Vaccin Antirabic Consumption Market Share by Type (2015-2020)
Figure 11. Global Vaccin Antirabic Value Market Share by Type (2015-2020)
Figure 12. Vaccin Antirabic Consumed in Pre-exposure Prophylaxis
Figure 13. Global Vaccin Antirabic Market: Pre-exposure Prophylaxis (2015-2020) (K Units)
Figure 14. Global Vaccin Antirabic Market: Pre-exposure Prophylaxis (2015-2020) ($ Millions)
Figure 15. Vaccin Antirabic Consumed in After Exposure Prophylaxis
Figure 16. Global Vaccin Antirabic Market: After Exposure Prophylaxis (2015-2020) (K Units)
Figure 17. Global Vaccin Antirabic Market: After Exposure Prophylaxis (2015-2020) ($ Millions)
Figure 18. Vaccin Antirabic Consumed in Additional Doses
Figure 19. Global Vaccin Antirabic Market: Additional Doses (2015-2020) (K Units)
Figure 20. Global Vaccin Antirabic Market: Additional Doses (2015-2020) ($ Millions)
Figure 21. Global Vaccin Antirabic Consumption Market Share by Application (2015-2020)
Figure 22. Global Vaccin Antirabic Value Market Share by Application (2015-2020)
Figure 23. Global Vaccin Antirabic Sales Market Share by Company in 2017
Figure 24. Global Vaccin Antirabic Sales Market Share by Company in 2019
Figure 25. Global Vaccin Antirabic Revenue Market Share by Company in 2017
Figure 26. Global Vaccin Antirabic Revenue Market Share by Company in 2019
Figure 27. Global Vaccin Antirabic Sale Price by Company in 2019
Figure 28. Global Vaccin Antirabic Consumption Market Share by Regions 2015-2020
Figure 29. Global Vaccin Antirabic Value Market Share by Regions 2015-2020
Figure 30. Americas Vaccin Antirabic Consumption 2015-2020 (K Units)
Figure 31. Americas Vaccin Antirabic Value 2015-2020 ($ Millions)
Figure 32. APAC Vaccin Antirabic Consumption 2015-2020 (K Units)
Figure 33. APAC Vaccin Antirabic Value 2015-2020 ($ Millions)
Figure 34. Europe Vaccin Antirabic Consumption 2015-2020 (K Units)
Figure 35. Europe Vaccin Antirabic Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Vaccin Antirabic Consumption 2015-2020 (K Units)
Figure 37. Middle East & Africa Vaccin Antirabic Value 2015-2020 ($ Millions)
Figure 38. Americas Vaccin Antirabic Consumption Market Share by Countries in 2019
Figure 39. Americas Vaccin Antirabic Value Market Share by Countries in 2019
Figure 40. Americas Vaccin Antirabic Consumption Market Share by Type in 2019
Figure 41. Americas Vaccin Antirabic Consumption Market Share by Application in 2019
Figure 42. United States Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 43. United States Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 45. Canada Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 47. Mexico Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Vaccin Antirabic Consumption Market Share by Countries in 2019
Figure 49. APAC Vaccin Antirabic Value Market Share by Regions in 2019
Figure 50. APAC Vaccin Antirabic Consumption Market Share by Type in 2019
Figure 51. APAC Vaccin Antirabic Consumption Market Share by Application in 2019
Figure 52. China Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 53. China Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 55. Japan Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 57. Korea Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 59. Southeast Asia Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 60. India Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 61. India Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 63. Australia Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Vaccin Antirabic Consumption Market Share by Countries in 2019
Figure 65. Europe Vaccin Antirabic Value Market Share by Countries in 2019
Figure 66. Europe Vaccin Antirabic Consumption Market Share by Type in 2019
Figure 67. Europe Vaccin Antirabic Consumption Market Share by Application in 2019
Figure 68. Germany Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 69. Germany Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 70. France Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 71. France Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 72. UK Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 73. UK Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 75. Italy Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 77. Russia Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Vaccin Antirabic Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Vaccin Antirabic Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Vaccin Antirabic Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Vaccin Antirabic Consumption Market Share by Application in 2019
Figure 82. Egypt Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 83. Egypt Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 85. South Africa Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 87. Israel Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 89. Turkey Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Vaccin Antirabic Consumption Growth 2015-2020 (K Units)
Figure 91. GCC Countries Vaccin Antirabic Value Growth 2015-2020 ($ Millions)
Figure 92. Global Vaccin Antirabic Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 93. Global Vaccin Antirabic Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 95. Americas Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 96. APAC Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 97. APAC Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 98. Europe Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 99. Europe Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 101. Middle East & Africa Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 102. United States Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 103. United States Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 104. Canada Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 105. Canada Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 106. Mexico Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 107. Mexico Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 108. Brazil Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 109. Brazil Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 110. China Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 111. China Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 112. Japan Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 113. Japan Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 114. Korea Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 115. Korea Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 117. Southeast Asia Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 118. India Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 119. India Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 120. Australia Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 121. Australia Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 122. Germany Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 123. Germany Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 124. France Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 125. France Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 126. UK Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 127. UK Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 128. Italy Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 129. Italy Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 130. Russia Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 131. Russia Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 132. Spain Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 133. Spain Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 134. Egypt Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 135. Egypt Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 136. South Africa Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 137. South Africa Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 138. Israel Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 139. Israel Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 140. Turkey Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 141. Turkey Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Vaccin Antirabic Consumption 2021-2025 (K Units)
Figure 143. GCC Countries Vaccin Antirabic Value 2021-2025 ($ Millions)
Figure 144. GSK Vaccin Antirabic Market Share (2018-2020)
Figure 145. Zhongke Biological Vaccin Antirabic Market Share (2018-2020)
Figure 146. Sanofi Vaccin Antirabic Market Share (2018-2020)
Figure 147. Yisheng Vaccin Antirabic Market Share (2018-2020)
Figure 148. Merck Vaccin Antirabic Market Share (2018-2020)
Figure 149. Chengda Vaccin Antirabic Market Share (2018-2020)
Figure 150. BCHT Vaccin Antirabic Market Share (2018-2020)
Figure 151. VACN Vaccin Antirabic Market Share (2018-2020)
Figure 152. Hissen Vaccin Antirabic Market Share (2018-2020)
Figure 153. Changsheng Vaccin Antirabic Market Share (2018-2020)
Figure 154. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Market Share (2018-2020)
Figure 155. Guangzhou Nuocheng Biological Vaccin Antirabic Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets